Shenzhen Chipscreen Biosciences(688321.SH): Xioroni capsules granted approval for drug clinical trials.

15:58 08/01/2026

Wison Biotechnology (688321.SH) announced that the company has recently received the "Notice of Approval for Clinical Trial of Drugs" issued by the National Medical Products Administration, which approved the company's product Xelione Capsules to carry out clinical research on the first-line treatment of metastatic pancreatic ductal adenocarcinoma in combination with Trepilumab and chemotherapy.

Shenzhen Chipscreen Biosciences (688321.SH) announced that the company has recently received a "Drug Clinical Trial Approval Notice" issued by the National Medical Products Administration, authorizing the company to conduct a clinical study on the combination of its product Xioloni capsules with Trepulimab and first-line chemotherapy for the treatment of metastatic pancreatic ductal adenocarcinoma.

HK Stock Market Move | XUNFEIHEALTH (02506) rose more than 10%, OpenAI released ChatGPT Health, the company is expected to greatly benefit from the development of AI healthcare.

HK Stock Market Move | FAST RETAIL-DRS (06288) rose more than 8% to a historical high. Revenue in the previous quarter increased by about 15% year-on-year. The company raised its full-year profit forecast.

New stocks news | Renewable fuel producer Eslite is considering a Hong Kong IPO listing, planning to raise approximately $1 billion.

HK Stock Market Move | XUNFEIHEALTH (02506) rose more than 10%, OpenAI released ChatGPT Health, the company is expected to greatly benefit from the development of AI healthcare.

New stocks news | Renewable fuel producer Eslite is considering a Hong Kong IPO listing, planning to raise approximately $1 billion.